T1	Participants 433 535	Ad Hoc Melanoma Working Group of 25 investigators treated 604 patients from April 1997 to January 2003
T2	Participants 138 175	Resected stage III cutaneous melanoma
T3	Participants 226 267	patients with resected stage III melanoma
